-
Science Immunology: How to maintain long-term memory of new coronavirus infection
Time of Update: 2021-10-22
Even older people have strong immune memoriesThe emergence of SARS-CoV-2 provides a unique opportunity for immunologists to study how the elderly respond to new pathogens .
-
Baoyuan Pharmaceutical and Cinda Biotech announce the interim data of the phase II trial of taletrectinib for ROS1-positive non-small cell lung cancer at the CSCO 2021 meeting
Time of Update: 2021-10-11
Among 21 patients who were not treated with crizotinib, the confirmed objective response rate (ORR) was 90. 5% (19/21), and the disease control rate (DCR) was 90. 5% (19/21) . Among the 16 patient
-
New energy power generation in Qinghai Province hit a new high
Time of Update: 2021-10-08
18 million kWh, and both new energy and wind power generated record highs.
Up to now, the total installed capacity of new energy across the entire network in Qinghai Province has reached 24.
-
[ESMO2021] A number of studies on gastrointestinal tumors bring new standard programs to China
Time of Update: 2021-10-01
The ORIENT-16 study became the first phase III clinical study in China that confirmed that PD-1 inhibitors combined with chemotherapy as the first-line treatment of advanced gastric cancer significantly prolonged survival in the overall population .
-
Small difference, big impact
Time of Update: 2021-10-01
In a new study published on "Cell Systems" on September 17, Beijing time, a research team led by Utrecht University in the Netherlands discovered the immune diversity of the population by drawing antibody maps of healthy individuals and patients, namely Everyone has their own unique serological antibody library .
-
Cell Reports: Scientists have discovered a conversion system for information processing and memory
Time of Update: 2021-08-15
The brain transfers the'sequence' of neural activity from encoding our experiences to recalling them, which shows that the same circuit plays a role in both information processing and memory.
-
GUT: Liver function at admission will affect the prognosis of patients with new coronary disease
Time of Update: 2021-08-02
Figure: The probability of abnormal liver enzymes and the severity of the new crown This study confirmed the admission LFT abnormalities, especially GGT and albumin levels are abnormal infection risk factors SARS-CoV-2 virus develop worsening disease .
-
Akzo Nobel Shanghai invests 6.5 million euros in new technology center opened
Time of Update: 2021-07-25
Global Coatings Network News: Dutch paint and coatings company Akzo Nobel held the opening ceremony of a new technology center with an investment of more than 6.
-
Research and propose a plum blossom weeping branch character regulation model
Time of Update: 2021-06-16
New progress has been made in the genetic regulation of plum blossom weeping branch traits .
7 was simultaneously located by 7 sub-traits, combined with GWAS, selective clearance analysis and candidate interval marker verification, the main QTL was finally reduced to 0.
-
Jiangsu Petroleum accelerates the development of new energy business
Time of Update: 2021-06-07
China Petroleum & Chemical News Network News Since this year, Jiangsu Petroleum has accelerated the development of new energy businesses such as charging, hydrogenation, and photovoltaics, and focused on building a green and diversified clean energy supply system.
-
Translational Psychiatry conducts mindfulness exercises during the COVID-19 pandemic to protect mental health
Time of Update: 2021-06-04
It is assumed that increasing mindfulness practice during the COVID-19 pandemic will be associated with positive changes in pandemic-related pain, depression, anxiety, and stress symptoms, especially among experienced practitioners.
-
BeiGene's BTK Inhibitor New Indications Marketing Application Accepted by FDA
Time of Update: 2021-06-02
It is reported that the application is mainly based on the results of a single-arm, open, multi-center phase 2 MAGNOLIA clinical trial of zebutinib for the treatment of patients with relapsed or refractory MZL, and a zebutinib against B-cell malignancies Supporting data from the global Phase 1/2 clinical trials.
-
Chilean cherries producer: striving to regain the trust of Chinese consumers
Time of Update: 2021-05-08
html" class="zdbq" title="Testing related food information" target="_blank">detected after a new crown positive storm, 2021/2022 cherry export season, he will try to convey confidence to the Chinese market.
-
The Peruvian avocado export season is about to start, and the export volume is expected to increase by 10
Time of Update: 2021-03-19
html" class="zdbq" title="Export-related food information" target="_blank">export volume of Peruvian avocados in 2021 is expected to reach 450,000 tons, which is a 10% increase over 2020.
html" class="zdbq" title="Export-related food information" target="_blank">exports From the perspective of the cultivation of Peruvian avocados, the report predicts that the production of Peruvian avocados in 2021 will reach 560,000 tons.
-
Gastroenterology: Why enteritis surgery causes secondary
Time of Update: 2021-03-09
compared the genetic activity in these patients' bag tissue with colon tissue samples from 11 patients with unacsolvened ulcerative colitis.
